BRYVORA Trademark

Trademark Overview


On Tuesday, July 19, 2022, a trademark application was filed for BRYVORA with the United States Patent and Trademark Office. The USPTO has given the BRYVORA trademark a serial number of 79347408. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by NOVARTIS AG. The BRYVORA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
bryvora

General Information


Serial Number79347408
Word MarkBRYVORA
Filing DateTuesday, July 19, 2022
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7039296
Registration DateTuesday, May 2, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the aforementioned excluding pharmaceutical preparations for the treatment of genetic diseases and disorders and pharmaceutical preparations for use in enzyme therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, December 18, 2023NOTIFICATION PROCESSED BY IB
Thursday, November 2, 2023GENERIC MADRID TRANSACTION SENT TO IB
Thursday, November 2, 2023IRREGULARITY FROM IB EXAMINED BY MPU
Thursday, November 2, 2023GENERIC MADRID TRANSACTION CREATED
Monday, September 18, 2023IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Thursday, August 10, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 10, 2023FINAL DISPOSITION PROCESSED
Wednesday, August 2, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Monday, February 13, 2023NOTIFICATION PROCESSED BY IB
Wednesday, January 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 25, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2023ATTORNEY REVIEW COMPLETED
Tuesday, January 10, 2023CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Sunday, January 8, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, November 26, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, October 26, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 25, 2022NON-FINAL ACTION WRITTEN
Monday, October 17, 2022ASSIGNED TO EXAMINER
Saturday, October 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, October 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Saturday, October 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, October 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 20, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, August 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 12, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB